In a 2015 study, Dr. Hayes and colleagues used mass spectrometry and immunohistochemistry (IHC) to demonstrate CD39 expression in sarcomas such as liposarcoma, fibrosarcoma, dermatofibrosarcoma, and leiomyosarcoma. This evidence concerns the gene ENTPD1 and sarcoma.